Click titles of paper presentations and symposia to view abstracts and outlines.
« Click to Return to Saturday’s Schedule
Times and topics are subject to change.*
| 6:00 – 10:00 a.m. | Registration | Peacock Foyer |
| 6:00 – 7:00 a.m. | Breakfast for All Attendees | Chantilly Foyer |
| 6:00 a.m. – 12:15 p.m. | AAHKS and Guest Society Poster Exhibition | Chantilly Ballroom |
| 7:00 a.m. – 7:15 a.m. | AAHKS Business Meeting Members nominate and vote on Board positions. |
Trinity Ballroom |
| 7:15 – 8:11 a.m. | Session Seven: Non-Arthroplasty and Other | Moderators: TBD |
| 7:15 a.m. Paper #39 |
What is the Impact of PAO Surgery on Patient Function and Activity Levels? | Jeff R. Petrie, MD Orlando, FL |
| 7:21 a.m. Paper #40 |
Surgical Treatment of Femoroacetabular Impingement: A Minimum 10-year Outcome and Risk Factors for Failure | Hamed Vahedi, MD Wayne, PA |
| 7:27 a.m. Paper #41 |
Hip Arthroscopy for Patients with Persistent Pain following Periacetabular Osteotomy: No Significant Changes in Pre- and Postoperative Patient Reported Outcomes | Mario Hevesi, MD Rochester, MN |
| 7:33 a.m. | Discussion | |
| 7:43 a.m. Paper #42 |
Hemiarthroplasty vs. Total Hip Arthroplasty for Femoral Neck Fractures: 2010-2017 Trends in Complication Rates | Juan C. Suarez, MD Miami, FL |
| 7:49 a.m. Paper #43 |
Patient and Surgeon Satisfaction with and Utility of Routine Follow-Up at One Year After Primary Total Hip and Total Knee Arthroplasty | Ryan M. Nunley, MD St. Louis, MO |
| 7:55 a.m. Paper #44 |
Can an Outpatient Risk Assessment Tool Predict Who Needs Postoperative Hemoglobin Monitoring? | John R. Martin, MD Charlotte, NC |
| 8:01 a.m. | Discussion | |
| 8:11 – 9:11 a.m. | Symposium VII: Periprosthetic Infection: A Practical Case-Based Approach | Moderator: Fares S. Haddad, MD, FRCS
Panelists: Stephen A. Jones, FRCS Thomas K. Fehring, MD Michael H. Huo, MD Thorsten M. Seyler, MD, PhD |
| 9:11 – 9:16 a.m. | The Hip Society Update | Presented by: TBD |
| 9:16 – 9:21 a.m. | The Knee Society Update | Presented by: TBD |
| 9:21 – 10:07 a.m. | Session Eight: The Opioid Crisis | Moderators: TBD |
| 9:21 a.m. Paper #45 |
Opioid Use After Discharge Following Primary Unilateral Total Knee Arthroplasty: How Much Are We Over-Prescribing? | Travis S. Scudday, MD Irvine, CA |
| 9:27 a.m. Paper #46 |
Education Increases Disposal of Unused Opioids after Total Joint Arthroplasty: A Cluster Randomized Trial | Charles P. Hannon, MD Chicago, IL |
| 9:33 a.m. Paper #47 |
Is Preoperative Tramadol a Safe Alternative to Opioids in Total Knee Arthroplasty? | David E. DeMik, MD Iowa City, IA |
| 9:39 a.m. Paper #48 |
The Effects of Opioid Use on Thromoboembolic Complications, Readmission Rates, and 90-Day Episode of Care Costs | Nipun Sodhi, MD New York, NY |
| 9:45 a.m. Paper #49 |
Use of Tetrahydrocannabinol and Cannabidiol Products in the Perioperative Period Around Primary Unilateral Total Knee Arthroplasty and the Impact on Opioid Consumption | Robert P. Runner, MD Irvine, CA |
| 9:51 a.m. | Discussion | |
| 10:01 – 11:01 a.m. | Symposium VIII: Tips and Tricks To Save You During Revision TKAs: Video-Based Demonstrations | Moderator: Matthew P. Abdel, MDPanelists: Daniel J. Berry, MD Craig J. Della Valle, MD Michael Meneghini, MD |
| 11:01 – 12:07 p.m. | Session Nine: Complications and Their Prevention | Moderators: TBD |
| 11:01 a.m. Paper #50 |
Does Intermittent Catheterization Compared to Indwelling Catheterization Decrease the Risk of Periprosthetic Joint Infection Following Total Knee Arthroplasty? | Luke Garbarino, MD New Hyde Park, NY |
| 11:07 a.m. Paper #51 |
Dilute Povidone-Iodine Solution Prevents Intraoperative Contamination of Sterile Water Basins during Total Joint Arthroplasty | James L. Galloway, MD Winston-Salem, NC |
| 11:13 a.m. Paper #52 |
A Randomized Clinical Trial of Articulating and Static Spacers in the Management of Chronic Periprosthetic Knee Infection | Cindy R. Nahhas, BS Chicago, IL |
| 11:19 a.m. | Discussion | |
| 11:29 a.m. Paper #53 |
Risk of Dislocation by Surgical Approach Following Modern Primary Total Hip Arthroplasty | Michael J. Taunton, MD Rochester, MN |
| 11:35 a.m. Paper #54 |
Does Femoral Component Cementation Affect Costs or Clinical Outcomes After Hip Arthroplasty in Medicare Patients? | Matthew S. Hepinstall, MD New York, NY |
| 11:41 a.m. Paper #55 |
Administration of Tranexamic Acid Improves Long-Term Outcomes in Total Knee Arthroplasty | Kenneth L. Urish, MD, PhD Pittsburgh, PA |
| 11:47 a.m. Paper #56 |
Traditional Intravenous Fluid vs. Oral Fluid Administration in Primary Total Knee Arthroplasty: A Randomized Trial | Jason M. Jennings, MD Denver, CO |
| 11:53 a.m. | Discussion | |
| 12:03 – 12:15 p.m. | Concluding Remarks | Michael P. Bolognesi, MD |
| 12:15 p.m. | Adjourn | |
| 12:15 – 1:00 p.m. | AAHKS and Guest Society Poster Take Down Any posters remaining after 1:00 p.m. will be discarded. |
Chantilly Ballroom |
*These podium presentations have not yet been assigned a position in the schedule. When AAHKS Paper Award winners are announced, they will be inserted, and the order of some presentations will shift.
Fixed-Bearing Medial Unicondylar Knee Arthroplasty – Slight Varus, Just Right!
Sean E. Slaven, MD
Bethesda, MD
Projections of Revision Hip and Knee Arthroplasty in The United States to 2030
Andrew M. Schwartz, MD
Atlanta, GA
Isolated Tibial Insert Exchange in Aseptic Revision TKA: Reliable & Durable for Wear; Less So for Instability, Insert Fracture/Dissociation, or Stiffness
Matthew W. Tetreault, MD
Rochester, MN
CME
The American Association of Hip and Knee Surgeons (AAHKS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Hip and Knee Surgeons (AAHKS) designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
AAHKS is committed to ensuring balance, independence, objectivity, and scientific rigor in their governance, programmatic, educational, and other activities. Board members, educational planners, faculty and staff, and anyone involved in a CME activity must disclose all relevant financial relationships with ACCME-defined commercial interests (including those of spouses, business partners, and immediate family members) within the last 12 months that actually or potentially could predispose or bias the individual to a particular decision, view, or goal in connection with the educational activity in which he or she is engaged.
Prior to the meeting, disclosures will be available for review here.